Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Illicit drug addiction, infectious disease spread, and the need for an evidence-based response.

Wood E, Montaner JS, Kerr T.

Lancet Infect Dis. 2008 Mar;8(3):142-3. doi: 10.1016/S1473-3099(08)70021-5. No abstract available.

PMID:
18291331
2.

Canada opposes harm reduction policies for drug users.

Webster PC.

CMAJ. 2014 Mar 4;186(4):256. doi: 10.1503/cmaj.109-4714. Epub 2014 Feb 3. No abstract available.

3.

Reducing the harm of "harm reduction".

Beirness DJ, Notarandrea R, Jesseman R, Perron M.

Clin Pharmacol Ther. 2008 Apr;83(4):523-5. doi: 10.1038/sj.clpt.6100509.

PMID:
18349874
4.
5.

Using words: the harm reduction conception of drug use and drug users.

Stafford N.

Int J Drug Policy. 2007 Mar;18(2):88-91. Epub 2007 Feb 20. No abstract available.

PMID:
17689350
6.
7.

Drug policy, harm and human rights: a rationalist approach.

Stevens A.

Int J Drug Policy. 2011 May;22(3):233-8. doi: 10.1016/j.drugpo.2011.02.003. Epub 2011 Apr 9.

PMID:
21481578
8.

Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.

Irwin KS, Fry CL.

Int J Drug Policy. 2007 Mar;18(2):75-83. Epub 2007 Jan 16.

PMID:
17689348
9.

Harm reduction and decriminalization in the United States: a personal perspective.

DuPont RL.

Subst Use Misuse. 1996 Dec;31(14):1929-45; discussion 1947-72.

PMID:
8969018
10.

Our society's response to the addictions.

Bromley JW.

Clin Chem. 1992 Aug;38(8B Pt 2):1530-1.

PMID:
1643734
11.

Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program.

Ritter A, Bammer G, Hamilton M, Mazerolle L; DPMP Team.

Drug Alcohol Rev. 2007 May;26(3):265-71.

PMID:
17454015
12.

Addiction science advocacy: mobilizing political support to influence public policy.

Polcin DL.

Int J Drug Policy. 2014 Mar;25(2):329-31. doi: 10.1016/j.drugpo.2013.11.002. Epub 2013 Nov 18. No abstract available.

13.

Harm reduction ethics: a promising basis for drug policy.

Miller P.

Drug Alcohol Rev. 2005 Nov;24(6):553-4. No abstract available.

PMID:
16361213
14.

US Public Health Agency involvement in youth-focused illicit drug policy, planning, and prevention at the local level, 1999-2003.

McBride DC, Terry-McElrath YM, VanderWaal CJ, Chriqui JF, Myllyluoma J.

Am J Public Health. 2008 Feb;98(2):270-7. doi: 10.2105/AJPH.2007.112524. Epub 2008 Jan 2.

15.

Ushering in another harm reduction era? Discursive authenticity, drug policy and research.

Hathaway AD.

Drug Alcohol Rev. 2005 Nov;24(6):549-50. No abstract available.

PMID:
16361211
16.

Drug Policy and the Public Good: a summary of the book.

Drugs and Public Policy Group.

Addiction. 2010 Jul;105(7):1137-45. doi: 10.1111/j.1360-0443.2010.03049.x.

PMID:
20642498
17.

Taming demons: the reduction of harm resulting from use of illicit drugs.

Wodak A.

Aust N Z J Med. 1992 Apr;22(2):204-8.

PMID:
1530547
18.

Drug policy in Vietnam: a decade of change?

Vuong T, Ali R, Baldwin S, Mills S.

Int J Drug Policy. 2012 Jul;23(4):319-26. doi: 10.1016/j.drugpo.2011.11.005. Epub 2011 Dec 27.

PMID:
22206713
19.

Canada moving backwards on illegal drugs.

Hyshka E, Butler-McPhee J, Elliott R, Wood E, Kerr T.

Can J Public Health. 2012 Mar-Apr;103(2):125-7.

PMID:
22530535
20.

The size and mix of government spending on illicit drug policy in Australia.

Moore TJ.

Drug Alcohol Rev. 2008 Jul;27(4):404-13. doi: 10.1080/09595230802093737.

PMID:
18584391

Supplemental Content

Support Center